SCHEMBL2827455

SCHEMBL2827455

C[Si](C)(C)Oc1ccco1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.40
ALDH1A1 P00352 6/20 0.36
POLB P06746 4/20 0.36
KDM4E B2RXH2 4/20 0.36
HPGD P15428 4/20 0.36
MEN1 O00255 3/20 0.36
MAPT P10636 3/20 0.36
PTPN7 P35236 3/20 0.36
RECQL P46063 3/20 0.36
BLM P54132 3/20 0.36
KMT2A Q03164 3/20 0.36
TDP1 Q9NUW8 3/20 0.36
PKM P14618 2/20 0.36
ALOX15 P16050 2/20 0.36
CASP1 P29466 2/20 0.36
CASP7 P55210 2/20 0.36
HSD17B10 Q99714 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
THRB P10828 2/20 0.36
ALOX12 P18054 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20515345 0.79 LMNA (0.32) ALDH1A1LMNAGAAHTT
SCHEMBL6983169 0.78 TP53 (0.34) TP53ALDH1A1POLBKDM4EHPGD
SCHEMBL2600449 0.78 TP53 (0.34) TP53ALDH1A1POLBKDM4EHPGD
SCHEMBL3174521 0.78 TP53 (0.34) TP53ALDH1A1POLBKDM4EHPGD
Water SCHEMBL5362631 0.75 POLB (0.32) TP53ALDH1A1POLBKDM4EHPGD
SCHEMBL827212 0.74
SCHEMBL1326408 0.73 TP53 (0.41) TP53ALDH1A1POLBKDM4EHPGD
SCHEMBL7743218 0.72
Water SCHEMBL29272691 0.70 TP53 (0.39) TP53ALDH1A1POLBKDM4EHPGD
Water SCHEMBL29272692 0.70 TP53 (0.39) TP53ALDH1A1POLBKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108690609-B Synthesis method of water-soluble or oil-soluble carbon dots and fluorescent carbon dots 中国科学院理化技术研究所 2021-05-14 CN claimed
US-10988488-B2 Process for the functionalization of sp2-H carbons using frustrated lewis pair catalysts UNIVERSITé LAVAL (CA) 2021-04-27 US claimed
US-20180094001-A1 PROCESS FOR THE FUNCTIONALIZATION OF SP2-H CARBONS USING FRUSTRATED LEWIS PAIR CATALYSTS UNIVERSITE LAVAL (CA) 2018-04-05 US claimed
EP-3298018-A1 PROCESS FOR THE FUNCTIONALIZATION OF SP2-H CARBONS USING FRUSTRATED LEWIS PAIR CATALYSTS. Université Laval (CA) 2018-03-28 EP claimed
WO-2016168914-A1 PROCESS FOR THE FUNCTIONALIZATION OF SP2-H CARBONS USING FRUSTRATED LEWIS PAIR CATALYSTS UNIVERSITé LAVAL (CA) 2016-10-27 WO claimed
US-7183354-B2 Room temperature curable functionalized HNBR coating LORD CORPORATION (US) 2007-02-27 US claimed
WO-2006003496-A2 PREPARATION OF 4-SUBSTITUTED-2-BUTEN-4-OLIDES FROM MUCOHALIC ACIDS WARNER-LAMBERT COMPANY LLC (US) 2006-01-12 WO claimed
US-20060004211-A1 Preparation of 4-substituted-2-buten-4-olides from mucohalic acids WARNER-LAMBERT COMPANY LLC 2006-01-05 US claimed
JP-3223292-A None JP disclosed
JP-4112882-A None JP disclosed
JP-4117374-A None JP disclosed
EP-4591314-A2 SELECTION OF CHEMICAL SYNTHESIS PROCESSES The Regents of The University of Michigan (US) 2025-07-30 EP disclosed
US-20250197416-A1 PARTHENOLIDE DERIVATIVES AND USE THEREOF UNIVERSITY OF ROCHESTER (US) 2025-06-19 US disclosed
US-11950438-B2 Inorganic light emitting diode and inorganic light emitting device including the same LG DISPLAY CO., LTD. (KR) 2024-04-02 US disclosed
US-5064649-A CEPHALOSPORIN DERIVATIVES BEECHAM GROUP P.L.C. (GB) 1991-11-12 US disclosed
JP-H03223292-A PENTACYCLIC COMPOUND FUJISAWA PHARMACEUT CO LTD 1991-10-02 JP disclosed
US-4973693-A ANTITUMOR AGENTS, MICROBIOCIDES, CHEMICAL INTERMEDIATES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-11-27 US disclosed
US-4965267-A LOW TOXICITY IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 1990-10-23 US disclosed
US-4923865-A Substituted 1-(1H-imidazol-4-yl)alkyl-benzamides as anti-ischemics and as alpha-2-adrenergic receptor agonists U C B SOCIETE ANONYME (BE) 1990-05-08 US disclosed
EP-0359536-A2 Cephalosporin compounds, process for their preparation and pharmaceutical compositions BEECHAM GROUP PLC (GB) 1990-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10988488-B2 Process for the functionalization of sp2-H carbons using frustrated lewis pair catalysts LEF1, FOS, PAX2 TP53 2682/4885ALDH1A1 3574/4885POLB 3634/4885
US-20180094001-A1 PROCESS FOR THE FUNCTIONALIZATION OF SP2-H CARBONS USING FRUSTRATED LEWIS PAIR CATALYSTS LEF1, FOS, PAX2 TP53 2682/4885ALDH1A1 3574/4885POLB 3634/4885
US-20250197416-A1 PARTHENOLIDE DERIVATIVES AND USE THEREOF CASP8, WEE1, CASP7 TP53 1944/4885ALDH1A1 3297/4885POLB 4583/4885
US-20060004211-A1 Preparation of 4-substituted-2-buten-4-olides from mucohalic acids MUC1, FUT6, FUT5 TP53 2953/4885ALDH1A1 332/4885POLB 3816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.